<table id="_RefID0EOIAI" width="90%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 4 Clarithromycin Susceptibility Test Results and Clinical/Bacteriological Outcomes</caption>
<col width="26%"></col>
<col width="10%"></col>
<col width="32%"></col>
<col width="7%"></col>
<col width="7%"></col>
<col width="8%"></col>
<col width="9%"></col>
<thead>
<tr>
<th align="center" colspan="6" stylecode="Toprule " valign="top">
<content stylecode="bold">Clarithromycin Susceptibility Test Results and Clinical/Bacteriological Outcomes<sup>a</sup>
</content>
</th>
</tr>
<tr>
<th align="center" colspan="2" valign="top">
<content stylecode="bold">Clarithromycin Pretreatment Results</content>
</th>
<th align="center" colspan="5" valign="top">
<content stylecode="bold">Clarithromycin Post-treatment Results</content>
</th>
</tr>
<tr>
<th align="left" valign="top"></th>
<th align="left" valign="top"></th>
<th align="center" valign="top">
<content stylecode="bold">
<content stylecode="italics">H. pylori</content> negative – eradicated</content>
</th>
<th align="center" colspan="4" valign="top">
<content stylecode="bold">
<content stylecode="italics">H. pylori</content> positive – not eradicated </content>
<br/>
<content stylecode="bold">Post-treatment susceptibility results</content>
</th>
</tr>
<tr>
<th align="left" stylecode="Botrule " valign="top"></th>
<th align="left" stylecode="Botrule " valign="top"></th>
<th align="left" stylecode="Botrule " valign="top"></th>
<th align="center" stylecode="Botrule " valign="top">
<content stylecode="bold">S<sup>b</sup>
</content>
</th>
<th align="center" stylecode="Botrule " valign="top">
<content stylecode="bold">I<sup>b</sup>
</content>
</th>
<th align="center" stylecode="Botrule " valign="top">
<content stylecode="bold">R<sup>b</sup>
</content>
</th>
<th align="center" stylecode="Botrule " valign="top">
<content stylecode="bold">No MIC</content>
</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="6" stylecode="Toprule ">
<paragraph>Dual Therapy – (omeprazole 40 mg once daily/clarithromycin 500 three times daily for 14 days followed by omeprazole 20 mg once daily for another 14 days) (Studies 4, 5)</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>Susceptible<sup>b</sup>
</paragraph>
</td>
<td>
<paragraph>108</paragraph>
</td>
<td>
<paragraph>72</paragraph>
</td>
<td>
<paragraph>1</paragraph>
</td>
<td></td>
<td>
<paragraph>26</paragraph>
</td>
<td>
<paragraph>9</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>Intermediate<sup>b</sup>
</paragraph>
</td>
<td>
<paragraph>1</paragraph>
</td>
<td></td>
<td></td>
<td></td>
<td>
<paragraph>1</paragraph>
</td>
<td></td>
</tr>
<tr>
<td>
<paragraph>Resistant<sup>b</sup>
</paragraph>
</td>
<td>
<paragraph>4</paragraph>
</td>
<td></td>
<td></td>
<td></td>
<td>
<paragraph>4</paragraph>
</td>
<td></td>
</tr>
<tr>
<td colspan="6">
<paragraph>Triple Therapy – (omeprazole 20 mg twice daily/clarithromycin 500 mg twice daily/amoxicillin 1 g twice daily for 10 days – Studies 1, 2, 3; followed by omeprazole 20 mg once daily for another 18 days – Studies 1, 2)</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>Susceptible<sup>b</sup>
</paragraph>
</td>
<td>
<paragraph>171</paragraph>
</td>
<td>
<paragraph>153</paragraph>
</td>
<td>
<paragraph>7</paragraph>
</td>
<td></td>
<td>
<paragraph>3</paragraph>
</td>
<td>
<paragraph>8</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>Intermediate<sup>b</sup>
</paragraph>
</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td stylecode="Botrule ">
<paragraph>Resistant<sup>b</sup>
</paragraph>
</td>
<td stylecode="Botrule ">
<paragraph>14</paragraph>
</td>
<td stylecode="Botrule ">
<paragraph>4</paragraph>
</td>
<td stylecode="Botrule ">
<paragraph>1</paragraph>
</td>
<td stylecode="Botrule "></td>
<td stylecode="Botrule ">
<paragraph>6</paragraph>
</td>
<td stylecode="Botrule ">
<paragraph>3</paragraph>
</td>
</tr>
</tbody>
</table>